Get my own profile
Public access
View all12 articles
2 articles
available
not available
Based on funding mandates
Co-authors
Daniel M DavisImperial College LondonVerified email at imperial.ac.uk- Christopher TapeGroup Leader, University College London Cancer InstituteVerified email at ucl.ac.uk
- Douglas LauffenburgerMITVerified email at mit.edu
- Gloria Lopez CastejonThe Lydia Becker Institute of Immunology and Inflammation, University of ManchesterVerified email at manchester.ac.uk
- Ashley R AmbroseUniversity of British ColumbiaVerified email at ubc.ca
- Stephanie LingAssociate Principal Scientist, AstraZenecaVerified email at astrazeneca.com
- John SinclairProteomics Technical Expert SyngentaVerified email at Syngenta.com
- Faraz MardakhehBarts Cancer InstituteVerified email at qmul.ac.uk
- Amine SadokSr. Director-Head of Discovery Technologies at Monte Rosa TherapeuticsVerified email at monterosatx.com
- David BroughUniversity of ManchesterVerified email at manchester.ac.uk
- Jack P GreenUniversity of ManchesterVerified email at manchester.ac.uk
- Matthias TrostNewcastle UniversityVerified email at newcastle.ac.uk
- Yinyin YuanThe Institute of Cancer Research, LondonVerified email at icr.ac.uk
- Marie Locard-PauletCNRS - IPBSVerified email at ipbs.fr
- Tracy HussellDirector of the Manchester Collaborative Centre for Inflammation Research and Professor ofVerified email at manchester.ac.uk
- Jeremy D. WaightGSKVerified email at gsk.com
- Tihana Lenac RovisUniversity of Rijeka, Faculty of MedicineVerified email at uniri.hr
- Stipan JonjicProfessor and Chair, Department of Histology and Embryology, Faculty of Medicine, University of RijekaVerified email at medri.uniri.hr
- Margherita BertuzziLecturer in Molecular Microbiology, University of ManchesterVerified email at manchester.ac.uk
